Literature DB >> 31437402

Bacteriophage Therapy of Ventilator-associated Pneumonia and Empyema Caused by Pseudomonas aeruginosa.

Susan Maddocks1,2,3, Aleksandra Petrovic Fabijan2, Josephine Ho2,4, Ruby C Y Lin2,3,5, Nouri L Ben Zakour2,3, Chris Dugan1, Ivana Kliman1, Steven Branston5, Sandra Morales5, Jonathan R Iredell1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31437402     DOI： 10.1164/rccm.201904-0839LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  20 in total

Review 1.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

2.  PHAGE Futures Congress Meeting Summary Washington, DC January 29 to 30, 2020.

Authors:  Shawna McCallin; Gina Suh; Jessica Sacher; Michael Koeris; Miguel Barreto; Bob Blasdel; Carl Merril; Shawna McCallin
Journal:  Phage (New Rochelle)       Date:  2020-06-16

3.  Targeted Phage Display-based Pulmonary Vaccination in Mice and Non-human Primates.

Authors:  Daniela I Staquicini; E Magda Barbu; Rachel L Zemans; Beth K Dray; Fernanda I Staquicini; Prashant Dogra; Marina Cardó-Vila; Cindy K Miranti; Wallace B Baze; Luisa L Villa; Jorge Kalil; Geetanjali Sharma; Eric R Prossnitz; Zhihui Wang; Vittorio Cristini; Richard L Sidman; Andrew R Berman; Reynold A Panettieri; Rubin M Tuder; Renata Pasqualini; Wadih Arap
Journal:  Med (N Y)       Date:  2020-12-10

4.  Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection model.

Authors:  Yu Lin; Diana Quan; Rachel Yoon Kyung Chang; Michael Y T Chow; Yuncheng Wang; Mengyu Li; Sandra Morales; Warwick J Britton; Elizabeth Kutter; Jian Li; Hak-Kim Chan
Journal:  Eur J Pharm Biopharm       Date:  2020-11-27       Impact factor: 5.571

5.  Turning the Phage on Treatment of Antimicrobial-Resistant Pneumonia.

Authors:  Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2019-11-01       Impact factor: 21.405

Review 6.  Targeting Plasmids to Limit Acquisition and Transmission of Antimicrobial Resistance.

Authors:  Corneliu Ovidiu Vrancianu; Laura Ioana Popa; Coralia Bleotu; Mariana Carmen Chifiriuc
Journal:  Front Microbiol       Date:  2020-05-06       Impact factor: 5.640

Review 7.  Potential of Therapeutic Bacteriophages in Nosocomial Infection Management.

Authors:  Nannan Wu; Tongyu Zhu
Journal:  Front Microbiol       Date:  2021-01-28       Impact factor: 5.640

Review 8.  Progress and Pitfalls of Bacteriophage Therapy in Critical Care: A Concise Definitive Review.

Authors:  Luca Valente; Josef Prazak; Yok-Ai Que; David R Cameron
Journal:  Crit Care Explor       Date:  2021-03-08

Review 9.  Systematic Literature Review of Real-world Evidence of Ceftolozane/Tazobactam for the Treatment of Respiratory Infections.

Authors:  Laura Puzniak; Ryan Dillon; Thomas Palmer; Hannah Collings; Ashley Enstone
Journal:  Infect Dis Ther       Date:  2021-07-18

Review 10.  Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.

Authors:  Corneliu Ovidiu Vrancianu; Irina Gheorghe; Elena-Georgiana Dobre; Ilda Czobor Barbu; Roxana Elena Cristian; Marcela Popa; Sang Hee Lee; Carmen Limban; Ilinca Margareta Vlad; Mariana Carmen Chifiriuc
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 6.208
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.